chr14-19921243-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005483.1(OR4K5):c.637C>T(p.Leu213Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,614,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005483.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR4K5 | NM_001005483.1 | c.637C>T | p.Leu213Phe | missense_variant | 1/1 | ENST00000315915.5 | |
LOC124903278 | XR_007064055.1 | n.166-14161G>A | intron_variant, non_coding_transcript_variant | ||||
OR4K1 | XM_011537153.3 | c.-122+931C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR4K5 | ENST00000315915.5 | c.637C>T | p.Leu213Phe | missense_variant | 1/1 | NM_001005483.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152224Hom.: 0 Cov.: 36
GnomAD3 exomes AF: 0.000442 AC: 111AN: 250974Hom.: 0 AF XY: 0.000442 AC XY: 60AN XY: 135606
GnomAD4 exome AF: 0.000179 AC: 261AN: 1461810Hom.: 0 Cov.: 32 AF XY: 0.000184 AC XY: 134AN XY: 727210
GnomAD4 genome AF: 0.000217 AC: 33AN: 152342Hom.: 0 Cov.: 36 AF XY: 0.000255 AC XY: 19AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.637C>T (p.L213F) alteration is located in exon 1 (coding exon 1) of the OR4K5 gene. This alteration results from a C to T substitution at nucleotide position 637, causing the leucine (L) at amino acid position 213 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at